| Identification | Back Directory | [Name]
1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]- | [CAS]
2805078-75-3 | [Synonyms]
Sitagliptin Impurity 59 (Sitagliptin Tablets EP Impurity FP-B)
1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]- | [Molecular Formula]
C16H13F6N5O2 | [MOL File]
2805078-75-3.mol | [Molecular Weight]
421.3 |
| Chemical Properties | Back Directory | [density ]
1.67±0.1 g/cm3(Predicted) | [solubility ]
DMSO (Slightly), Methanol (Slightly, Heated) | [form ]
Solid | [pka]
12.02±0.40(Predicted) | [color ]
White to Off-White |
| Hazard Information | Back Directory | [Uses]
Sitagliptin Triazecine Analog is related to the family of Sitagliptin compounds which has recently been approved for the therapy of type II diabetes. |
|
|